Gina Lacuesta
Overview
Explore the profile of Gina Lacuesta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacuesta G, Betschel S, Tsai E, Kim H
Allergy Asthma Clin Immunol
. 2024 Dec;
20(Suppl 3):65.
PMID: 39654054
Angioedema can occur in the absence of urticaria and can be broadly divided into three main categories: mast cell-mediated (e.g., histamine), non-mast-cell-mediated (bradykinin-induced) and idiopathic angioedema. Non-mast-cell-mediated angioedema is largely...
2.
Fitzpatrick T, Yamoah P, Lacuesta G, Sadarangani M, Cook V, Pourshahnazari P, et al.
Vaccine
. 2024 Jun;
42(24):126078.
PMID: 38910092
Background: COVID-19 vaccination has been associated with anaphylaxis and hypersensitivity reactions. Infectious disease physicians and allergists in the Canadian Special Immunization Clinic (SIC) Network developed guidance for evaluating patients with...
3.
Maurer M, Albuquerque M, Boursiquot J, Dery E, Gimenez-Arnau A, Godse K, et al.
Adv Ther
. 2023 Nov;
41(1):14-33.
PMID: 37991694
Chronic urticaria (CU) is the recurring development of wheals (aka "hives" or "welts"), angioedema, or both for more than 6 weeks. Wheals and angioedema occur with no definite triggers in...
4.
Keith P, Cowan J, Kanani A, Kim H, Lacuesta G, Lee J, et al.
Allergy Asthma Clin Immunol
. 2023 Jun;
19(1):54.
PMID: 37353830
No abstract available.
5.
Mendivil J, DerSarkissian M, Banerji A, Diwakar L, Katelaris C, Keith P, et al.
Allergy Asthma Clin Immunol
. 2023 May;
19(1):48.
PMID: 37248521
Background: Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, recurring subcutaneous or submucosal swelling. Without effective therapy, HAE can negatively impact patients' quality of life. Management of HAE...
6.
Chair I, Lacuesta G, Nash C, Cook V
CMAJ
. 2023 Jan;
195(2):E91-E96.
PMID: 36649959
No abstract available.
7.
Chair I, Lacuesta G, Nash C, Cook V
CMAJ
. 2022 Sep;
194(37):E1283-E1287.
PMID: 36162836
No abstract available.
8.
Keith P, Cowan J, Kanani A, Kim H, Lacuesta G, Lee J, et al.
Allergy Asthma Clin Immunol
. 2022 Aug;
18(1):70.
PMID: 35934726
Background: Real-world data on transitioning to Immune Globulin Subcutaneous (Human) 20% solution (Ig20Gly) are limited. This study aimed to assess infusion parameters and experience of patients with primary (PID) or...
9.
Iaboni A, Kanani A, Lacuesta G, Song C, Kan M, Betschel S
Allergy Asthma Clin Immunol
. 2021 Jul;
17(1):78.
PMID: 34301329
Background: Hereditary angioedema (HAE) is a rare autosomal dominant disease resulting in recurring episodes of swelling, leading to considerable patient morbidity and mortality. Lanadelumab is a plasma kallikrein inhibitor that...
10.
Lee E, Hsieh J, Caballero T, McCusker C, Kanani A, Lacuesta G, et al.
Ann Allergy Asthma Immunol
. 2021 Jul;
128(1):89-94.e1.
PMID: 34298173
Background: Data on the clinical and demographic features of Canadian patients with hereditary angioedema (HAE) are lacking. Objective: To describe the clinical and demographic features in a large Canadian HAE...